Liposomes for controlled delivery of drugs to the lung

Taylor, K M; Newton, J M
April 1992
Thorax;Apr1992, Vol. 47 Issue 4, p257
Academic Journal
No abstract available.


Related Articles

  • Novel possibilities of development and therapeutic applications of Liposomes. Kalyankar, T. M.; Khan, Mubeena; Rangari, Nalanda T.; Wagh, Vijay D. // Journal of Pharmacy Research;Aug2010, Vol. 3 Issue 8, p1880 

    Liposomes are one of the unique drug delivery system, which can be of potential use in controlling and targeting drug delivery. Liposomes are administered orally, topically and parentally as well as use in cosmetics and hair technologies, sustained release formulations, diagnostic purpose and as...

  • A novel approach for lung delivery of rifampicin-loaded liposomes in dry powder form for the treatment of tuberculosis. Patil, Jagadevappa S.; Devi, V. Kusum; Devi, Kshama; Sarasija, S. // Lung India;Jul/Aug2015, Vol. 32 Issue 4, p331 

    Background: Lung administration of antibiotics by nebulization is promising for improved treatment efficiency for pulmonary infections, as it increases drug concentration at sites of infection while minimizing systemic side effects. For poorly soluble molecules like rifampicin, lipid particulate...

  • APPROACHES AND DEVICES USED IN PULMONARY DRUG DELIVERY SYSTEM: A REVIEW. Gangurde, H. H.; Chordiya, M. A.; Baste, N. S.; Tamizharasi, S.; Upasani, C. D. // Asian Journal of Pharmaceutical Research & Health Care;Jan2012, Vol. 4 Issue 1, p11 

    Targeting drug delivery into the lungs has become one of the most important aspects of systemic or local drug delivery. Consequently, in the last few years, techniques and new drug delivery devices intended to deliver drugs into the lungs have been widely developed. Currently, the main drug...

  • Drugs that turn on.  // New Scientist;12/7/91, Vol. 132 Issue 1798, p27 

    Describes a new drug delivery system under development by researchers at the Center for Controlled Chemical Delivery at the University of Utah in Salt Lake City. Who would be best suited for this method; Disadvantage of liposomes, a drug delivery system.

  • A Liposomal Drug Platform Overrides Peptide Ligand Targeting to a Cancer Biomarker, Irrespective of Ligand Affinity or Density. Gray, Bethany Powell; McGuire, Michael J.; Brown, Kathlynn C. // PLoS ONE;Aug2013, Vol. 8 Issue 8, p1 

    One method for improving cancer treatment is the use of nanoparticle drugs functionalized with targeting ligands that recognize receptors expressed selectively by tumor cells. In theory such targeting ligands should specifically deliver the nanoparticle drug to the tumor, increasing drug...

  • Liposomes (a Review). Chrai, Suggy S.; Murari, R.; Ahmad, Imran // BioPharm International;Nov2001, Vol. 14 Issue 11, p10 

    Discusses the advantages of liposomal drug delivery systems and their necessity in vivo and clearance from the body. Utilization of liposomal formulations in biopharmaceutical development projects; Methods employed in making liposomal systems for drug delivery; Mechanisms of introducing drugs...

  • Specific features of drug encapsulation in liposomes (A review). Tazina, E.; Kostin, K.; Oborotova, N. // Pharmaceutical Chemistry Journal;Oct2011, Vol. 45 Issue 8, p481 

    Liposomes are hollow particles, the internal space of which is bounded by a lipid membrane. Liposomes are promising drug delivery systems for organs and tissues because of their colloidal properties, controlled size, surface characteristics, membrane action, and biocompatibility. Liposomal drugs...

  • Design of Anti-Bacterial Drug and Anti-Mycobacterial Drug for Drug Delivery System. Yanagihara, Katsunori // Current Pharmaceutical Design;Mar2002, Vol. 8 Issue 6, p475 

    Liposome-encapsulated drugs often exhibit reduced toxicity and have also been shown to enhance retention of drugs in the tissues. Thus, encapsulation of drugs in liposomes has often resulted in an improved overall therapeutic efficacy. The results of efficacy of liposome-encapsulated...

  • A Review on Composite Liposomal Technologies for Specialized Drug Delivery. Mufamadi, Maluta S.; Pillay, Viness; Choonara, Yahya E.; Du Toit, Lisa C.; Modi, Girish; Naidoo, Dinesh; Ndesendo, Valence M. K. // Journal of Drug Delivery;2011, p1 

    The combination of liposomes with polymeric scaffolds could revolutionize the current state of drug delivery technology. Although liposomes have been extensively studied as a promising drug delivery model for bioactive compounds, there still remain major drawbacks for widespread pharmaceutical...

  • Intratracheal Versus Intravenous Liposomal Delivery of siRNA, Antisense Oligonucleotides and Anticancer Drug. Olga Garbuzenko; Maha Saad; Seema Betigeri; Min Zhang; David Reimer; Vitaly Pozharov; Tamara Minko // Pharmaceutical Research;Feb2009, Vol. 26 Issue 2, p382 

    Abstract Purpose  To compare systemic intravenous and local intratracheal delivery of doxorubicin (DOX), antisense oligonucleotides (ASO) and small interfering RNA (siRNA). Methods  “Neutral” and cationic liposomes were used to deliver DOX, ASO, and siRNA. Liposomes...


Read the Article


Sign out of this library

Other Topics